Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regular Meeting
wpmaster
GEXVal Inc.
February 24, 2022
Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regular Meeting
GEXVal will appear at the Pitch Presentation session of the 299th Japan Pharmaceutical Licensing Association (JPLA) regular meeting on March 4, 2022. This meeting is a network event where licensing specialists in the pharmaceutical industry get together. This time the meeting will be held online.
GEXVal’s mission is to deliver drugs for orphan and intractable diseases to as many patients as possible. We are not engaged in the 3 development pipelines generated through strategic / comprehensive drug repurposing research. To provide medicinal products to healthcare professionals as soon as possible, it is necessary to accelerate research and development through partnering. We will strive for such an opportunity and explore collaboration opportunities in various ways.
Meeting date and time and details
Date and time: Friday, March 4, 2022 at 17:00 to 19:00 (Plan)
Venue: Online meeting (ZOOM large scale meeting)
Member registration is required for participation.
Top Page of Japan Pharmaceutical Licensing Association (JPLA) (jpla-tokyo.jp)
What is Japan Pharmaceutical Licensing Association?
Japan Pharmaceutical Licensing Association (JPLA) is an association with an aim to improve performance, expand knowledge, and enhance communications among members through collaborative research and development for new drugs and exchange of practical experiences and knowledge in licensing business, etc. Top Page of Japan Pharmaceutical Licensing Association (JPLA) (jpla-tokyo.jp)
For further information, please contact us: info@gexval.com
